Literature DB >> 16730486

Oral contraceptive use and risk of fractures.

Peter Vestergaard1, Lars Rejnmark, Leif Mosekilde.   

Abstract

INTRODUCTION: Prior studies have suggested that oral contraceptives (OCs) may be associated with an increased fracture risk. However, the previous studies have only performed a limited adjustment for other potential risk factors. SUBJECTS AND METHODS: All women with a fracture (n=64,548) in the year 2000 in Denmark served as cases. For each case, three age-matched controls were randomly drawn from the general population (n=193,641). Exposure was use of OCs between January 1, 1996, and December 31, 2000. Adjustments were made for use of other drugs, pregnancy, prior fracture, other diseases and social variables.
RESULTS: In the unadjusted analysis, use of OCs in low dose was associated with a small increase in overall fracture risk. However, upon adjustment, no increase in fracture risk could be demonstrated in any age or dose group.
CONCLUSION: Oral contraceptives are not associated with an increase or a decrease in fracture risk. Any change in fracture risk may be due to confounders.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16730486     DOI: 10.1016/j.contraception.2006.01.006

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  8 in total

1.  Oral contraceptive use and fracture risk around the menopausal transition.

Authors:  Delia Scholes; Andrea Z LaCroix; Rebecca A Hubbard; Laura E Ichikawa; Leslie Spangler; Belinda H Operskalski; Nancy Gell; Susan M Ott
Journal:  Menopause       Date:  2016-02       Impact factor: 2.953

2.  Oral contraceptive use and fracture risk-a retrospective study of 12,970 women in the UK.

Authors:  S Dombrowski; L Jacob; P Hadji; K Kostev
Journal:  Osteoporos Int       Date:  2017-04-13       Impact factor: 4.507

Review 3.  Current pharmacological options for the management of primary hyperparathyroidism.

Authors:  Peter Vestergaard
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 4.  Steroidal contraceptives and bone fractures in women: evidence from observational studies.

Authors:  Laureen M Lopez; Mario Chen; Sarah Mullins Long; Kathryn M Curtis; Frans M Helmerhorst
Journal:  Cochrane Database Syst Rev       Date:  2015-07-21

5.  Hormonally Active Contraceptives Part I: Risks Acknowledged and Unacknowledged.

Authors:  William V Williams; Joel Brind; Laura Haynes; Michael D Manhart; Hanna Klaus; Angela Lanfranchi; Gerard Migeon; Mike Gaskins; Elvis I Seman; Lester Ruppersberger; Kathleen M Raviele
Journal:  Linacre Q       Date:  2021-01-27

6.  Consensus Statement on the Use of Oral Contraceptive Pills in Polycystic Ovarian Syndrome Women in India.

Authors:  Duru Shah; Madhuri Patil
Journal:  J Hum Reprod Sci       Date:  2018 Apr-Jun

Review 7.  The clinical relevance of progestogens in hormonal contraception: Present status and future developments.

Authors:  Pedro-Antonio Regidor
Journal:  Oncotarget       Date:  2018-10-02

Review 8.  Bone health in estrogen-free contraception.

Authors:  P Hadji; E Colli; P-A Regidor
Journal:  Osteoporos Int       Date:  2019-08-24       Impact factor: 4.507

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.